ST2在心血管疾病方面研究新进展(4)
[21] Wzang T J,Wollert K C,Larson M G,et al.Prognostic utility of novel biomarkers of cardiovascular stress:the framingham heart study[J].Circulation,2012,126(13):1596-1604.
[22] Chen L Q,de Lemos J A,Das S R,et al.Soluble ST2 is associated with all-cause and cardiovascular mortality in a population based cohort:the dallas heart study[J].Clin Chem,2013,59(3):536-546.
[23]Ho J E,Sritara P,de Filippi C R,et al.Soluble ST2 testing in the general population[J].Am J Cardiol,2015,115(7 Suppl):22B-25B.
[24] Ho J E,Larson M G,Ghorbani A,et al.Soluble ST2 predicts elevated SBP in the community[J].J HyperLens,2013,31(7):1431-1436.
[25] Lupón J,Gaggin H K,de Antonio M,et al.Biomarker-assist score for reverse remodelling prediction in heart failure:the ST2-R2 score[J].Int J Cardiol,2015,185C(1):337-343.
[26] Lupón J,Sanders-van Wijk S,Januzzi J L,et al.Prediction of survival and magnitude of reverse remodeling using the ST2-R2 score in heart failure: A multicenter study[J].Int J Cardiol,2016,204(12):242-247.
[27]许亚妹,葛均波.新型心衰标志物sST2的生物学特征和临床意义[J].中华检验医学杂志,2015,38(7):498-501.(黄静 陈还珍 韩瑾 吴振华)
微信文章
关注百拇
评论几句
搜索更多
|